Diffuse panbronchiolitis history and symptoms: Difference between revisions
Line 10: | Line 10: | ||
DPB can be characterized by a number of symptoms and [[histopathology|histological]] features (those detected by analysis of tissues). | DPB can be characterized by a number of symptoms and [[histopathology|histological]] features (those detected by analysis of tissues). | ||
If left untreated, as DPB progresses, signs of bronchiectasis begin to present themselves. These symptoms include chronic shortness of breath, severe cough, pooling of sputum, thickening of bronchiolar walls, hypoxemia, and dilation (enlargement) of the bronchiolar passages.<ref name=dpb>{{cite journal |author=Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T |title=Diffuse panbronchiolitis. A disease of the transitional zone of the lung |journal=Chest. |volume=83 |issue=1 |pages=63-69 |year=1983 |pmid=6848335 }}</ref><ref name=usa>{{cite journal |author=Fitzgerald JE, King TE Jr., Lynch DA, Tuder RM, Schwarz MI |title=Diffuse panbronchiolitis in the United States |journal=Am J Respir Crit Care Med. |volume=154 |issue=2 pt. 1 |pages=497-503 |year=1996 |pmid=8756828 }}</ref> This eventually becomes life-threatening, leading to respiratory failure.<ref name=dpb>{{cite journal |author=Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T |title=Diffuse panbronchiolitis. A disease of the transitional zone of the lung |journal=Chest. |volume=83 |issue=1 |pages=63-69 |year=1983 |pmid=6848335 }}</ref> | If left untreated, as DPB progresses, signs of bronchiectasis begin to present themselves. These symptoms include chronic [[shortness of breath]], severe [[cough]], pooling of [[sputum]], thickening of [[bronchiolar walls]], [[hypoxemia]], and dilation (enlargement) of the bronchiolar passages.<ref name=dpb>{{cite journal |author=Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T |title=Diffuse panbronchiolitis. A disease of the transitional zone of the lung |journal=Chest. |volume=83 |issue=1 |pages=63-69 |year=1983 |pmid=6848335 }}</ref><ref name=usa>{{cite journal |author=Fitzgerald JE, King TE Jr., Lynch DA, Tuder RM, Schwarz MI |title=Diffuse panbronchiolitis in the United States |journal=Am J Respir Crit Care Med. |volume=154 |issue=2 pt. 1 |pages=497-503 |year=1996 |pmid=8756828 }}</ref> This eventually becomes life-threatening, leading to [[respiratory failure]].<ref name=dpb>{{cite journal |author=Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T |title=Diffuse panbronchiolitis. A disease of the transitional zone of the lung |journal=Chest. |volume=83 |issue=1 |pages=63-69 |year=1983 |pmid=6848335 }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 16:21, 24 September 2012
Diffuse panbronchiolitis Microchapters |
Differentiating Diffuse panbronchiolitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Diffuse panbronchiolitis history and symptoms On the Web |
American Roentgen Ray Society Images of Diffuse panbronchiolitis history and symptoms |
Risk calculators and risk factors for Diffuse panbronchiolitis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Symptoms
DPB can be characterized by a number of symptoms and histological features (those detected by analysis of tissues).
If left untreated, as DPB progresses, signs of bronchiectasis begin to present themselves. These symptoms include chronic shortness of breath, severe cough, pooling of sputum, thickening of bronchiolar walls, hypoxemia, and dilation (enlargement) of the bronchiolar passages.[1][2] This eventually becomes life-threatening, leading to respiratory failure.[1]
References
- ↑ 1.0 1.1 Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T (1983). "Diffuse panbronchiolitis. A disease of the transitional zone of the lung". Chest. 83 (1): 63–69. PMID 6848335.
- ↑ Fitzgerald JE, King TE Jr., Lynch DA, Tuder RM, Schwarz MI (1996). "Diffuse panbronchiolitis in the United States". Am J Respir Crit Care Med. 154 (2 pt. 1): 497–503. PMID 8756828.